Last reviewed · How we verify

NCT04811456: MOIS-CoR

MultiOrgan Inflammatory Syndromes COVID-19 Related Study

Status unknown Last updated 26 March 2021
What this trial tests

trial testing multisystem inflammatory syndrome in children (MIS-C) in Covid19 in 1,000 participants. Status unknown.

Timeline
25 May 2020
Primary endpoint
25 May 2025
25 August 2025

Quick facts

Lead sponsorMedical University of Warsaw
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date25 May 2020
Primary completion25 May 2025
Estimated completion25 August 2025
Sites2 locations across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Warsaw

Who can join

Under 18, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study comprise a nationwide, voluntary, on-line survey of inflammatory syndromes in children for retrospective (since 4th March 2020) and prospective data collection. Our aim was to capture and describe multisystem inflammatory syndrome in children (MIS-C) in Poland.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other Medical University of Warsaw trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04811456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing